NCT04130828View on ClinicalTrials.gov

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

January 18, 2022

Study Completion Date

January 18, 2022

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferrous Fumarate

Ferrous fumarate 200 mg PO PC

Trial Locations (1)

90110

Songklanagarind Hospital, Hat Yai

All Listed Sponsors
collaborator

The Thai Society of Hematology

UNKNOWN

lead

Prince of Songkla University

OTHER

NCT04130828 - Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia | Biotech Hunter | Biotech Hunter